Literature DB >> 31201693

Modern Esophageal Function Testing and Gastroesophageal Reflux Disease in Morbidly Obese Patients.

Ivan Kristo1, Matthias Paireder1, Gerd Jomrich1, Daniel M Felsenreich2, Milena Nikolic1, Felix B Langer2, Gerhard Prager2, Sebastian F Schoppmann3.   

Abstract

BACKGROUND: The implementation of high-resolution manometry (HRM) and the Lyon Consensus statement facilitate evaluation of gastroesophageal reflux disease and motility disorders in morbidly obese patients. Therefore, we aimed to investigate prevalence and phenotype of (borderline) GERD and esophageal motility disorders in this population.
METHODS: Consecutive morbidly obese (BMI ≥ 35 kg/m2) patients were offered evaluation by means of HRM, ambulatory 24-h pH impedance monitoring, endoscopy, and a clinical examination at our tertiary academic center. Data were collected prospectively.
RESULTS: Out of 448 eligible individuals, 147 patients (females = 75, 51%) with a median age of 41.6 (33.4; 52.3) years and a BMI of 44 (40.9; 49.4) kg/m2 were included during the study period. The Chicago Classification revealed motility disorders in 50 (34%) patients, dominated by outflow obstruction (18.4%, n = 27) and a novel disorder (7.5%, n = 11), nicknamed jackhammer esophagus (JE). According to the Lyon Consensus, 52 (35.4%) patients had evidence of true GERD, whereas borderline GERD was noted in another 60 (40.8%). Hypersensitive esophagus was observed in 6.8% (n = 10). Sensitivity and specificity of symptoms for GERD were 53.8% and 68.4%, respectively.
CONCLUSIONS: The current gold standard of assessment revealed that the prevalence of esophageal motility disorders and (borderline) GERD is high in the morbidly obese population. Further longitudinal data are needed to delineate the natural course of novel motility disorders like JE in obesity and to identify risk factors for adverse outcomes following bariatric surgery.

Entities:  

Keywords:  Gastroesophageal reflux disease; Morbidly obese; Motility disorders

Mesh:

Year:  2019        PMID: 31201693     DOI: 10.1007/s11695-019-04020-1

Source DB:  PubMed          Journal:  Obes Surg        ISSN: 0960-8923            Impact factor:   4.129


  3 in total

1.  From Nissen Fundoplication to Roux-en-Y Gastric Bypass to Treat Both GERD and Morbid Obesity.

Authors:  Niccolo' Petrucciani; Lionel Sebastianelli; Sébastien Frey; Antonio Iannelli
Journal:  Obes Surg       Date:  2020-02       Impact factor: 4.129

2.  Relationship Between Bariatric Surgery and Gastroesophageal Reflux Disease: a Systematic Review and Meta-analysis.

Authors:  Lihu Gu; Bangsheng Chen; Nannan Du; Rongrong Fu; Xiaojing Huang; Feiyan Mao; Parikshit Asutosh Khadaroo; Shenbiao Zhao
Journal:  Obes Surg       Date:  2019-12       Impact factor: 4.129

3.  Outcomes of routine upper gastrointestinal series screening and surveillance after laparoscopic adjustable gastric banding.

Authors:  Danielle T Friedman; Andrew J Duffy
Journal:  Surg Endosc       Date:  2019-07-25       Impact factor: 4.584

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.